Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Topiramate
Janssen-Cilag Pty Ltd
Medicine Registered
TOPAMAX ® TABLETS AND SPRINKLE CAPSULES _Topiramate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about TOPAMAX ® tablets and Sprinkle capsules. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking TOPAMAX against the benefits it is expected to have for you. If you have any concerns about taking TOPAMAX, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. WHAT TOPAMAX IS USED FOR TOPAMAX is used for the treatment of various types of epilepsy in adults and children over 2 years of age, and for the prevention of migraines in adults. It prevents seizures and migraines by acting on the nerves and chemicals in the brain. TOPAMAX is not used to treat severe migraines that come on suddenly (acute). Your doctor may prescribe TOPAMAX on its own, or in addition to another medicine for controlling your seizures or migraines. Your doctor may have prescribed TOPAMAX for another reason. Ask your doctor if you have any questions about why this medicine has been prescribed for you. BEFORE YOU TAKE TOPAMAX WHEN YOU MUST NOT TAKE IT Do not take TOPAMAX: • if you have an allergy to it or to any of the ingredients. See PRODUCT DESCRIPTION at the end of this leaflet for a list of ingredients. • if the tablets or capsules are not as described under Product Description at the end of this leaflet. Do not take TOPAMAX if the packaging is torn or shows signs of tampering. Do not take TOPAMAX after the expiry date (month and year) printed on the pack. BEFORE YOU START TO TAKE IT You must tell your doctor if you: • are pregnant or planning to become pregnant. Topamax has Les hele dokumentet
_____________________________________________________________________________________________________ jcptopam10513.docx Page 1 of 27 CCDS130204 TOPAMAX ® TABLETS AND SPRINKLE CAPSULES PRODUCT INFORMATION NAME OF THE MEDICINE Topiramate DESCRIPTION Topiramate [2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate] is a white crystalline powder with a bitter taste. It is most soluble in alkaline solutions containing sodium hydroxide or sodium phosphate and has a pH of 9 to 10. It is freely soluble in acetone, chloroform, dimethylsulfoxide and ethanol. The solubility in water is 9.8 mg/mL. Its saturated solution has a pH of 6.3. C 12 H 21 NO 8 S CAS-97240-79-4 MW: 339.36 TOPAMAX tablets contain topiramate, and the inactive ingredients lactose, pregelatinised maize starch, carnauba wax, microcrystalline cellulose, sodium starch glycollate, magnesium stearate, and the OPADRY ® coating and colouring for each tablet comprising titanium dioxide, hypromellose, lauromacrogol 400 and polysorbate 80. Additionally, in the coating, the 50 mg and 100 mg tablets contain iron oxide yellow, and the 200 mg and 300 mg tablets contain iron oxide red. TOPAMAX Sprinkle capsules consist of sugar spheres enclosed in a gelatin capsule. The sugar spheres contain topiramate, povidone, cellulose acetate and sucrose. The capsule shells contain gelatin and titanium dioxide, and are imprinted with black ink. PHARMACOLOGY PHARMACODYNAMICS Topiramate is classified as a sulfamate substituted monosaccharide. Three pharmacological properties of topiramate have been identified that may contribute to its anticonvulsant activity: • Topiramate reduces the frequency at which action potentials are generated when neurons are subjected to a sustained depolarisation, which is indicativ Les hele dokumentet